You are here

  • Home
  • Archive
  • Volume 106, Issue 3
  • Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease

Article metrics

Article menu

Download PDFPDF

Clinical science
Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 202015531535663
Dec 2020188018621147
Jan 202145945445
Feb 202134433834
Mar 202126726333
Apr 202128227746
May 202130630524
Jun 202121121217
Jul 202119118533
Aug 202120720539
Sep 202120620330
Oct 202120219348
Nov 202120320047
Dec 202118118018
Jan 202217417426
Feb 202274674349
Mar 202245144766
Apr 202222121943
May 202220620147
Jun 202221821228
Jul 2022440440151
Aug 202221020843
Sep 202213212639
Oct 202214214219
Nov 2022919127
Dec 2022867719
Jan 2023857822
Feb 202311910718
Mar 202311610023
Apr 2023636122
May 2023949224
Jun 2023555316
Jul 2023443712
Aug 2023958320
Sep 202362629
Oct 2023757416
Nov 2023676211
Dec 2023594018
Jan 2024383620
Feb 2024363227
Mar 20245548163
Apr 2024735232
May 2024595322
Jun 2024514914
Jul 2024707019
Aug 2024464315
Sep 2024575227
Oct 2024434019
Nov 2024615812
Total11132108743362